Provectus Biopharmaceuticals Inc (PVCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 8,086 | 3,237 | 2,796 | 350 | 630 |
| Other current assets | 0 | 0 | 0 | 7,010 | 6,680 |
| TOTAL | $8,086 | $3,237 | $2,847 | $7,360 | $7,310 |
| Non-Current Assets | |||||
| PPE Net | 21 | 30 | 34 | 40 | 30 |
| Intangibles | 6,268 | 6,939 | 7,610 | 0 | 0 |
| Other Non-Current Assets | 27 | 27 | 27 | 8,300 | 8,974 |
| TOTAL | $6,317 | $6,997 | $7,671 | $8,340 | $9,004 |
| Total Assets | $14,403 | $10,234 | $10,518 | $15,710 | $16,320 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 419 | 220 | 267 | 450 | 60 |
| Accrued Expenses | 891 | 192 | 146 | 420 | 370 |
| Other current liabilities | N/A | 345 | N/A | 0 | 0 |
| TOTAL | $1,350 | $827 | $462 | $880 | $800 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 2,353 | 0 | 0 | 0 | 0 |
| TOTAL | $2,353 | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $3,703 | $827 | $462 | $880 | $800 |
| Shareholders' Equity | |||||
| Common Shares | 91 | 67 | 53 | 40 | 40 |
| Retained earnings | -86,350 | -67,798 | -55,476 | -45,200 | -35,200 |
| Other shareholders' equity | 0 | 0 | 0 | 10 | 0 |
| TOTAL | $10,700 | $9,407 | $10,056 | $14,830 | $15,520 |
| Total Liabilities And Equity | $14,403 | $10,234 | $10,518 | $15,710 | $16,320 |